• Use of recombinant human glutamic acid decarboxylase (GAD65)
• Ready-to-use (exception: wash buffer), color- and barcoded reagents
• Quality assured handling in routine laboratories
• Incubation at room temperature
• Quantitative determination of antibodies against GAD65)
• Calibrated with the international standard preparation NIBSC code 97/550
• Results expressed in IU/mL
• Excellent diagnostic sensitivity and specificity
• High precision within the measurement range
• CE marked
• Fully automatable
3507 – Medizym® anti-GAD M
Autoimmunity, Diagnostics, ELISA
3507 – Medizym® anti-GAD M
Enzyme immunoassay for the quantitative determination of antibodies against Glutamic Acid Decarboxylase (GAD65) in human serum
Available Downloads:
| Indication | Diabetes mellitus Type 1 |
|---|---|
| Format | Microtiter plate coated with recombinant human GAD65 |
| Total incubation time | 160 min. |
| No. of determinations | 96 (89 x 1) + 6 x Calibrators and 1 x Control |
Related products
-
4006 – ASCA IgA
Enzyme immunoassay for the quantitative determination of IgA antibodies against Saccharomyces cerevisiae in human serum
-
8101, 81040 – ANA HEp-2 plus
Immunofluorescence assay (IFA) for the determination of IgG antibodies against nuclear and cytoplasmic antigens (ANA) in human serum
-
3506 – Medizym® anti-IA2 M
Enzyme immunoassay for the quantitative determination of antibodies against Protein Tyrosine Phosphatase (IA2) in human serum